Heartland Advisors’s Albireo Pharma Inc ALBO Stock Holding History

Heartland Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-70,000	Closed	-$2.47M	–	234
2021 Q1	$2.47M	Hold	70,000	–	–	0.16%	185
2020 Q4	$2.63M	Sell	70,000 -30,000	-30%	-$1.09M	0.19%	175
2020 Q3	$3.34M	Sell	100,000 -50,000	-33%	-$1.46M	0.29%	132
2020 Q2	$3.97M	Hold	150,000	–	–	0.35%	115
2020 Q1	$2.46M	Buy	150,000 +50,000	+50%	+$1.1M	0.26%	134
2019 Q4	$2.54M	Sell	100,000 -33,000	-25%	-$660K	0.19%	150
2019 Q3	$2.66M	Hold	133,000	–	–	0.2%	148
2019 Q2	$4.29M	Sell	133,000 -17,000	-11%	-$569K	0.32%	128
2019 Q1	$4.83M	Buy	150,000 +25,000	+20%	+$673K	0.36%	120
2018 Q4	$3.07M	Hold	125,000	–	–	0.25%	140
2018 Q3	$4.12M	Hold	125,000	–	–	0.28%	141
2018 Q2	$4.44M	Buy	125,000 +33,677	+37%	+$1.09M	0.29%	137
2018 Q1	$2.97M	Buy	+91,323	New	+$3.07M	0.2%	166

Other funds holding ALBO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Heartland Advisors's ALBO Position: Q2 2021 in Review

Heartland Advisors sold out of Albireo Pharma Inc (ALBO) in Q2 2021, closing a stake of 70,000 shares — an estimated $2.47M sold.

Heartland Advisors first reported a position in ALBO in Q1 2018 and held it in 13 quarters. The position peaked at $4.83M in Q1 2019. 99 funds tracked by Wall St. Rank hold ALBO as of Q2 2021.

Heartland Advisors reported no remaining Albireo Pharma Inc position as of Q2 2021 after selling out during the quarter.
Heartland Advisors sold 70,000 Albireo Pharma Inc shares in Q2 2021, an estimated $2.47M.
Heartland Advisors first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 13 quarters.
Heartland Advisors's Albireo Pharma Inc position peaked at $4.83M in Q1 2019.
99 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2021.

Based on Heartland Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.